SH Healthcare Investment No.1 Association Corrects 1-Share Discrepancy in NGeneBio Stake ... Purely Administrative Fix with No Financial Impact
On July 10, 2026, SH Healthcare Investment No.1 Association filed a correction to its previously submitted report on ownership of specific securities by executives and major shareholders.
The correction addresses a 1-share discrepancy arising from fractional share treatment after the 3:1 reverse stock split effective June 25, 2026.
Post-correction, the association holds 1,961,925 shares of NGeneBio, representing 21.95% ownership, unchanged except for the trivial adjustment of 737 KRW relative to the market cap of approximately 1,975 billion KRW.
[AI Summary]This amendment is purely administrative with no impact on the company's financial position or shareholder value. The correction is neutral and immaterial.
KOSDAQ Filing Information
[Correction of Description] Report on Ownership of Specific Securities, etc. by Executives and Major Shareholders
Company: NGeneBio (354200)
Submission: SH Healthcare Investment No.1 Association